MEOPA (equimolar mixture of oxygen and protoxide of nitrogen) versus local anesthetic for analgesia during the biopsy of trophoblast
Phase 1
- Conditions
- Pregnancy and biopsy of trophoblastTherapeutic area: Body processes [G] - Physiological processes [G07]
- Registration Number
- EUCTR2012-005361-12-FR
- Lead Sponsor
- HOPITAL SAINT JOSEPH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- 240
Inclusion Criteria
Medical indication of biopsy of trophoblast
Monofoetal pregnancy
First quarter of pregnancy
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 240
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range 0
Exclusion Criteria
Contraindication of the realization of biopsy of trophoblast
Contraindication of the use of MEOPA or KALINOX
Contraindication of the use of local anesthetic
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Determine if the efficiency of the analgesia by MEOPA si equivalent at least to that of the local anesthetic in the biopsy of trophoblast during the first quarter of the pregnancy. The main criteria of evaluation will be represented by the efficiency of the analgesia measured through an analog visual scale of the pain in the immediate fall of the realization of the biopsy of trophoblast;Secondary Objective: The secondary criteria of evaluation will be represented by the evaluation of the anxiety, the disconfort and the pain felt before, during and after the act.;Primary end point(s): End of study : visit of the last patient (240th patient);Timepoint(s) of evaluation of this end point: After 36 months of the duration of the study
- Secondary Outcome Measures
Name Time Method Secondary end point(s): Not applicable;Timepoint(s) of evaluation of this end point: February 2016